.: ORİJİNAL ARAŞTIRMA
Anesteziyoloji ve Reanimasyon Yoğun Bakımlarından Servislere Nakli Yapılan COVID-19 Hastalarının Semptomları ve Uzamış Taburculuk Değerlendirmesi: Retrospektif Bir Çalışma
Symptoms and Prolonged Discharge Evaluation of COVID-19 Patients Transferred from Anesthesiology and Reanimation Intensive Care Units to Services: A Retrospective Study
Turkiye Klinikleri J Anest Reanim. 2021;19(3):133-9
doi: 10.5336/anesthe.2021-86661
Makale Dili: TR
Tam Metin
ÖZET
Amaç: Şiddetli akut solunum yolu sendromu-koronavirüs-2'nin neden olduğu koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] pandemisi döneminde sağlık kaynaklarını en iyi kullanmak, gelecekteki talebi tahmin edebilmek için hastaların hastane bakımına ne kadar süre ihtiyacı olduğunu belirlemek önemlidir. COVID-19 nedeniyle yoğun bakımda tedavisi tamamlanan ve servislere nakil olan hastaların hastanede kalış sürelerini değerlendirerek uzamış taburculuğu etkileyen faktörlerin belirlenmesi amaçlandı. Gereç ve Yöntemler: Retrospektif çalışmaya 8 aylık dönemde COVID-19 nedeniyle yoğun bakımda tedavisi tamamlanan ve servislerde takip sonrası eve taburcu olan erişkin hastalar dâhil edildi. Yatış süresine göre farklılaşan Grup 1 (servis yatış gün sayısı <7 gün, n=149) ve Grup 2 (servis yatış gün sayısı ≥7 gün, n=114) arasında semptomlar ve komorbid hastalıklar karşılaştırıldı. Bulgular: Çalışmamıza dâhil edilen 263 hastanın %53'ü (n=139) erkek, %47'si (n=124) kadın, yaş ortalaması 67,39±13,79 yıl olarak bulundu. Koroner arter hastalığı, Alzheimer hastalığı, kanser tanısı ve devam eden oksijen tedavisi ihtiyacı olan hastaların oranı Grup 2'de Grup 1'e göre daha yüksek bulundu (p=0,047; p=0,001; p=0,012 ve p<0,001). Sonuç: COVID-19 hastalarında koroner arter hastalığı, Alzheimer hastalığı, kanser tanısı ve devam eden oksijen tedavisi ihtiyacı uzun hastane yatışını etkileyen faktörlerdir. Devam eden oksijen tedavisi ihtiyacı nedeniyle servislerde takip edilen seçilmiş hastalara evde oksijen tedavisi uygulanabileceği kanaatindeyiz.
Anahtar Kelimeler: COVID-19; taburculuk; yandaş hastalık
Amaç: Şiddetli akut solunum yolu sendromu-koronavirüs-2'nin neden olduğu koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] pandemisi döneminde sağlık kaynaklarını en iyi kullanmak, gelecekteki talebi tahmin edebilmek için hastaların hastane bakımına ne kadar süre ihtiyacı olduğunu belirlemek önemlidir. COVID-19 nedeniyle yoğun bakımda tedavisi tamamlanan ve servislere nakil olan hastaların hastanede kalış sürelerini değerlendirerek uzamış taburculuğu etkileyen faktörlerin belirlenmesi amaçlandı. Gereç ve Yöntemler: Retrospektif çalışmaya 8 aylık dönemde COVID-19 nedeniyle yoğun bakımda tedavisi tamamlanan ve servislerde takip sonrası eve taburcu olan erişkin hastalar dâhil edildi. Yatış süresine göre farklılaşan Grup 1 (servis yatış gün sayısı <7 gün, n=149) ve Grup 2 (servis yatış gün sayısı ≥7 gün, n=114) arasında semptomlar ve komorbid hastalıklar karşılaştırıldı. Bulgular: Çalışmamıza dâhil edilen 263 hastanın %53'ü (n=139) erkek, %47'si (n=124) kadın, yaş ortalaması 67,39±13,79 yıl olarak bulundu. Koroner arter hastalığı, Alzheimer hastalığı, kanser tanısı ve devam eden oksijen tedavisi ihtiyacı olan hastaların oranı Grup 2'de Grup 1'e göre daha yüksek bulundu (p=0,047; p=0,001; p=0,012 ve p<0,001). Sonuç: COVID-19 hastalarında koroner arter hastalığı, Alzheimer hastalığı, kanser tanısı ve devam eden oksijen tedavisi ihtiyacı uzun hastane yatışını etkileyen faktörlerdir. Devam eden oksijen tedavisi ihtiyacı nedeniyle servislerde takip edilen seçilmiş hastalara evde oksijen tedavisi uygulanabileceği kanaatindeyiz.
Anahtar Kelimeler: COVID-19; taburculuk; yandaş hastalık
ABSTRACT
Objective: During the severe acute respiratory syndrome coronavirus disease (COVID-19) pandemic, it is important to determine how long patients need hospital care in order to optimize health resources and predict future demand. It was aimed to determine the factors affecting the prolonged discharge by evaluating the length of stay in the hospital of patients who were treated in the intensive care unit and transferred to the wards due to COVID-19. Material and Methods: Adult patients who were treated in the intensive care unit due to COVID-19 during the 8-month period and were discharged home after follow-up in the wards were included in the retrospective study. Symptoms and comorbid diseases were compared between Group 1 (number of service hospitalization days <7 days, n=149) and Group 2 (service hospitalization days ≥7 days, n=114), which differed according to length of hospitalization. Results: A total of 263 patients, 53% (n=139) male, 47% (n=124) female, with a mean age of 67.39±13.79 years, were included in the study. The proportion of patients with coronary artery disease, Alzheimer's disease, cancer diagnosis and needing ongoing oxygen therapy was higher in Group 2 than in Group 1 (p=0.047; p=0.001; p=0.012 and p<0.001). Conclusion: Coronary artery disease, Alzheimer's disease, cancer diagnosis and the need for ongoing oxygen therapy are the factors affecting the long hospital stay in COVID-19 patients. We believe that home oxygen therapy can be applied to selected patients followed in the wards due to the ongoing need for oxygen therapy.
Keywords: COVID-19; patient discharge; co-morbidity
Objective: During the severe acute respiratory syndrome coronavirus disease (COVID-19) pandemic, it is important to determine how long patients need hospital care in order to optimize health resources and predict future demand. It was aimed to determine the factors affecting the prolonged discharge by evaluating the length of stay in the hospital of patients who were treated in the intensive care unit and transferred to the wards due to COVID-19. Material and Methods: Adult patients who were treated in the intensive care unit due to COVID-19 during the 8-month period and were discharged home after follow-up in the wards were included in the retrospective study. Symptoms and comorbid diseases were compared between Group 1 (number of service hospitalization days <7 days, n=149) and Group 2 (service hospitalization days ≥7 days, n=114), which differed according to length of hospitalization. Results: A total of 263 patients, 53% (n=139) male, 47% (n=124) female, with a mean age of 67.39±13.79 years, were included in the study. The proportion of patients with coronary artery disease, Alzheimer's disease, cancer diagnosis and needing ongoing oxygen therapy was higher in Group 2 than in Group 1 (p=0.047; p=0.001; p=0.012 and p<0.001). Conclusion: Coronary artery disease, Alzheimer's disease, cancer diagnosis and the need for ongoing oxygen therapy are the factors affecting the long hospital stay in COVID-19 patients. We believe that home oxygen therapy can be applied to selected patients followed in the wards due to the ongoing need for oxygen therapy.
Keywords: COVID-19; patient discharge; co-morbidity
REFERANSLAR:
- Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, B Pearson CA, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18(1):270. [Crossref] [PubMed] [PMC]
- Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9. Erratum in: JAMA. 2020;323(20):2098. [Crossref] [PubMed] [PMC]
- Rosenbaum L. Facing Covid-19 in Italy-ethics, logistics, and therapeutics on the epidemic's front line. N Engl J Med. 2020;382(20):1873-5. [Crossref] [PubMed]
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. [Crossref] [PubMed]
- Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577-83. [Crossref] [PubMed] [PMC]
- Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359-86. [Crossref] [PubMed] [PMC]
- Kummer BR, Klang E, Stein LK, Dhamoon MS, Jetté N. History of stroke is independently associated with in-hospital death in patients with COVID-19. Stroke. 2020;51(10):3112-4. [Crossref] [PubMed] [PMC]
- Wu S, Xue L, Legido-Quigley H, Khan M, Wu H, Peng X, et al. Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital. PLoS One. 2020;15(10):e0240959. [Crossref] [PubMed] [PMC]
- Jin YH, Zhan QY, Peng ZY, Ren XQ, Yin XT, Cai L, et al; Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM); Chinese Research Hospital Association (CRHA). Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version). Mil Med Res. 2020;7(1):41. [Crossref] [PubMed] [PMC]
- Cipriani A, Capone F, Donato F, Molinari L, Ceccato D, Saller A, et al. Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis. Intern Emerg Med. 2021;16(2):419-27. [Crossref] [PubMed] [PMC]
- Wargny M, Potier L, Gourdy P, Pichelin M, Amadou C, Benhamou PY, et al; CORONADO investigators. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021; 64(4):778-94. [Crossref] [PubMed] [PMC]
- Ielapi N, Licastro N, Provenzano M, Andreucci M, Franciscis S, Serra R. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomark Med. 2020;14(9):713-6. [Crossref] [PubMed] [PMC]
- Loffi M, Piccolo R, Regazzoni V, Di Tano G, Moschini L, Robba D, et al. Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection. Open Heart. 2020;7(2): e001428. [Crossref] [PubMed] [PMC]
- Li J, Long X, Huang H, Tang J, Zhu C, Hu S, et al. Resilience of Alzheimer's disease to COVID-19. J Alzheimers Dis. 2020;77(1):67-73. [Crossref] [PubMed] [PMC]
- Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. [Crossref] [PubMed] [PMC]
- Shen C, Yue X, Wang J, Shi C, Li W. Nocturnal oxygen therapy as an option for early COVID-19. Int J Infect Dis. 2020;98:176-9. [Crossref] [PubMed] [PMC]
- Sardesai I, Grover J, Garg M, Nanayakkara PWB, Di Somma S, Paladino L, et al. Short term home oxygen therapy for COVID-19 patients: The COVID-HOT algorithm. J Family Med Prim Care. 2020;9(7):3209-19. [Crossref] [PubMed] [PMC]
- Jiang B, Wei H. Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients. Eur Rev Med Pharmacol Sci. 2020;24(19):10239-46. [PubMed]
- Dadhwal R, Sharma M, Surani S. Restrictive lung disease in patients with subclinical coronavirus infection: are we bracing ourselves for devastating sequelae? Cureus. 2021;13(1):e12501. [Crossref] [PubMed] [PMC]
- Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020;20(4):411-2. [Crossref] [PubMed] [PMC]
- Lin L, Jiang X, Zhang Z, Huang S, Zhang Z, Fang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69(6):997-1001. [Crossref] [PubMed] [PMC]
.: İşlem Listesi